Brakha C, Arvers P, Villiers F, Marlu A, Buhot A, Livache T
Springerplus. 2014; 3:56.
PMID: 24516785
PMC: 3915053.
DOI: 10.1186/2193-1801-3-56.
Bain C, Parroche P, Lavergne J, Duverger B, Vieux C, Dubois V
J Virol. 2004; 78(19):10460-9.
PMID: 15367612
PMC: 516386.
DOI: 10.1128/JVI.78.19.10460-10469.2004.
Kotwal G
Mol Biotechnol. 2001; 16(3):271-89.
PMID: 11252811
DOI: 10.1385/MB:16:3:271.
Buratti E, Di Michele M, Song P, Monti-Bragadin C, Scodeller E, Baralle F
Clin Diagn Lab Immunol. 1997; 4(2):117-21.
PMID: 9067642
PMC: 170488.
DOI: 10.1128/cdli.4.2.117-121.1997.
Ando Y, Sonnerborg A, Barkholt L, Birkett A, Ericzon B, Sallberg M
Clin Diagn Lab Immunol. 1997; 4(1):104-6.
PMID: 9008291
PMC: 170485.
DOI: 10.1128/cdli.4.1.104-106.1997.
Chimeric hepatitis B virus core particles with parts or copies of the hepatitis C virus core protein.
Yoshikawa A, Tanaka T, Hoshi Y, Kato N, Tachibana K, Iizuka H
J Virol. 1993; 67(10):6064-70.
PMID: 8396669
PMC: 238027.
DOI: 10.1128/JVI.67.10.6064-6070.1993.
Isotype-specific immune response to a single hepatitis C virus core epitope defined by a human monoclonal antibody: diagnostic value and correlation to PCR.
Siemoneit K, da Silva Cardoso M, Wolpl A, Epple S, Wintersinger H, Koerner K
Ann Hematol. 1994; 69(3):129-33.
PMID: 8086507
DOI: 10.1007/BF01695693.
Hepatitis C: progress and problems.
Cuthbert J
Clin Microbiol Rev. 1994; 7(4):505-32.
PMID: 7834603
PMC: 358339.
DOI: 10.1128/CMR.7.4.505.
Hepatitis C virus (HCV) core serotypes in chronic HCV infection.
Mondelli M, Cerino A, Bono F, Cividini A, Maccabruni A, Arico M
J Clin Microbiol. 1994; 32(10):2523-7.
PMID: 7814491
PMC: 264095.
DOI: 10.1128/jcm.32.10.2523-2527.1994.
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.
Koziel M, Dudley D, Afdhal N, Choo Q, Houghton M, Ralston R
J Virol. 1993; 67(12):7522-32.
PMID: 7693974
PMC: 238218.
DOI: 10.1128/JVI.67.12.7522-7532.1993.
Identification of four epitopes in hepatitis C virus core protein.
Ferroni P, Mascolo G, Zaninetti M, Colzani D, Pregliasco F, Pirisi M
J Clin Microbiol. 1993; 31(6):1586-91.
PMID: 7686184
PMC: 265582.
DOI: 10.1128/jcm.31.6.1586-1591.1993.
Correlation of serum antibody titers against hepatitis C virus core protein with clinical features by western blot (immunoblot) analysis using a recombinant vaccinia virus expression system.
Nishizono A, Hiraga M, Mifune K, Terao H, Fujioka T, Nasu M
J Clin Microbiol. 1993; 31(5):1173-8.
PMID: 7684748
PMC: 262898.
DOI: 10.1128/jcm.31.5.1173-1178.1993.
Expression of hepatitis C virus core protein as a fusion protein with maltose binding protein. Detection of anti-hepatitis C core antibody by western blot.
Yokosuka O, Ito Y, Sakuma J, Imazeki F, OHTO M, Omata M
Dig Dis Sci. 1993; 38(4):626-30.
PMID: 7681745
DOI: 10.1007/BF01316791.
DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid.
Major M, Vitvitski L, Mink M, Schleef M, Whalen R, Trepo C
J Virol. 1995; 69(9):5798-805.
PMID: 7637024
PMC: 189445.
DOI: 10.1128/JVI.69.9.5798-5805.1995.
Human monoclonal antibodies for the immunological characterization of a highly conserved protein domain of the hepatitis C virus glycoprotein E1.
Siemoneit K, Cardoso M, Koerner K, Wolpl A, Kubanek B
Clin Exp Immunol. 1995; 101(2):278-83.
PMID: 7544250
PMC: 1553251.
DOI: 10.1111/j.1365-2249.1995.tb08351.x.
IgM and IgA antibodies generated against hepatitis C virus core antigen in patients with acute and chronic HCV infection.
Sato S, Fujiyama S, Tanaka M, Goto M, Taura Y, Kawano S
Dig Dis Sci. 1994; 39(9):2022-31.
PMID: 7521823
DOI: 10.1007/BF02088141.
Immunodominant regions within the hepatitis C virus core and putative matrix proteins.
Sallberg M, Ruden U, Wahren B, Magnius L
J Clin Microbiol. 1992; 30(8):1989-94.
PMID: 1380007
PMC: 265429.
DOI: 10.1128/jcm.30.8.1989-1994.1992.
Clinical evaluation of three anti-HCV ELISAs in patients with various liver diseases.
Kawano S, Fujiyama S, Sato S, Tanaka M, Goto M, Taura Y
Dig Dis Sci. 1992; 37(8):1268-74.
PMID: 1379905
DOI: 10.1007/BF01296571.
Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus.
Ching W, Wychowski C, Beach M, Wang H, Davies C, Carl M
Proc Natl Acad Sci U S A. 1992; 89(8):3190-4.
PMID: 1373489
PMC: 48831.
DOI: 10.1073/pnas.89.8.3190.
HCV RNA and antibody to HCV core protein in Japanese patients with chronic liver disease.
Yuki N, Hayashi N, Hagiwara H, Takehara T, Kasahara A, Fusamoto H
Dig Dis Sci. 1992; 37(10):1483-8.
PMID: 1327684
DOI: 10.1007/BF01296490.